Because transcription coactivator EP300 and ribosomal proteins RPS27A and RPS27 are not ideal biomarkers or therapeutic targets for HCC, CDK1, RAD21, and HDAC2 were chosen for subsequent analysis because they had relatively high degrees in the PPI network. The gene discussed is HDAC2; the disease is hepatocellular carcinoma.